-transparent.png){kind=logo}
Oxolinic acid was successfully used in eradicating bacteriuria in 86% of a highly selected group of 42 patients with chronic and recurrent urinary infections. Thirty-eight (92%) of patients had underlying renal abnormalities, 19 (45%) had impaired renal function. Emergence of resistant organisms in 3 patients (7%), and a high incidence of side effects necessitating withdrawal of treatment in 12 patients (29%), limit the usefulness of this agent to special situations. In patients with moderate and severe renal impairment, oxolinic acid achieves adequate urinary concentration, does not accumulate in the serum and is not nephrotoxic. The drug is safe and effective to use in patients with renal impairment.
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
January 1967,
Antimicrobial agents and chemotherapy,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
July 1971,
Pennsylvania medicine,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
July 1979,
Minerva medica,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
January 1972,
Pennsylvania medicine,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
January 1978,
Therapia Hungarica (English edition),
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
April 1973,
International journal of clinical pharmacology, therapy and toxicology,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
November 1970,
Delaware medical journal,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
January 1976,
Acta paediatrica Academiae Scientiarum Hungaricae,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
June 1978,
Therapie der Gegenwart,
S Kalowski, and
P Kincaid-Smith, and
R Pavillard
January 1977,
American journal of diseases of children (1960),
